Prof. Lemmens

Retirement

ao. Univ. Prof. Mag. Dr. Rosa Lemmens

e-mail: rosa.lemmens@univie.ac.at

Galanski M, Erker T, Studenik C , Kamyar M-R, Rawnduzi P, Pabstova M et al. Synthesis and pharmacological profile of non-peptide vasopressin antagonists. European Journal of Pharmaceutical Sciences. 2005;24(5):421-431. doi: 10.1016/j.ejps.2004.12.008

Kamyar M-R, Rawnduzi P, Studenik C, Kouri K, Lemmens R. Investigation of the electrophysiological properties of enniatins. Archives of Biochemistry and Biophysics. 2004;429(2):215-223. doi: 10.1016/j.abb.2004.06.013

Kouri K, Kamyar M-R, Lemmens R. Actions of the antibiotic mycotoxins beauvericin and enniatin on mammalian tissue. Forum of Nutrition. 2003;56:413-414.

Kouri K, Lemmens M, Lemmens R. Beauvericin-induced channels in ventricular myocytes and liposomes. Biochimica et Biophysica Acta - Biomembranes. 2003;1609(2):203-210. doi: 10.1016/S0005-2736(02)00689-2

Rajamani S, Studenik C, Lemmens R, Heistracher P. Cardiotoxic effects of fenfluramine hydrochloride on isolated cardiac preparations and ventricular myocytes of guinea-pigs. British Journal of Pharmacology. 2000;129(5):843-852.

Lemmens R. Patent focus on agents affecting cardiovascular and renal functions. November 1999-March 2000. Expert Opinion on Therapeutic Patents: authoritative analysis of patenting trends. 2000;10(5):533-548.

Lemmens-Gruber R, Rachoy B, Steininger E, Kouri K, Saleh P, Krska R et al. The effect of the Fusarium metabolite beauvericin on electromechanical and -physiological properties in isolated smooth and heart muscle preparations of guinea pigs. Mycopathologia. 2000;149(1):5-12. doi: 10.1023/A:1007293812007

Erker T, Lemmens R, Lexer A, Heistracher P, Galanski M, Erfinder*innen. 1-Substituierte Thieno(2,3-b)(1,4)thiazin-Derivate sowie 4-substituierte 1,4-Benzothiazin- und 1,4-Benzoxazin-Derivate mit einer gewebsspezifischen Wirkung auf die Kontraktionskraft. AT 403.918. 2000.

Heistracher P, Lemmens R, Fleischhacker W, Ecker G, Noe C, Erfinder*innen. Pharmakologisch aktive in Position 3 substituierte alpha-Aminomethyl-2-benzofuranmethanole. PCT WO 9217464. 1992.